Literature DB >> 26603359

The Relationship Between High-Sensitivity C-Reactive Protein Levels and Left Ventricular Hypertrophy in Patients With Newly Diagnosed Hypertension.

Ergun Seyfeli1, Bahadir Sarli2, Hayrettin Saglam2, Can Y Karatas3, Eyup Ozkan2, Mehmet Ugurlu2.   

Abstract

The authors aimed to evaluate the relationship between high-sensitivity C-reactive protein (hs-CRP) and presence of left ventricular hypertrophy and diastolic dysfunction in patients with hypertension. A total of 95 newly diagnosed hypertensive patients (mean age, 54±10 years) and 20 controls were included in this study. Patients were divided into four groups according to relative wall thickness as normal, concentric remodeling, concentric, and eccentric hypertrophy. hs-CRP was measured in all patients and serum hs-CRP level was shown to be increased in patients with hypertension compared with controls (0.57 mg/dL vs 0.25 mg/dL, respectively; P<.001). The hs-CRP level was highest in patients with concentric hypertrophy. When compared with controls, serum hs-CRP level was significantly higher in patients with concentric remodeling (0.61±0.3 mg/dL vs 0.43±0.5 mg/dL, P<.030) and concentric hypertrophy (0.69±0.3 mg/dL vs 0.43±0.5 mg/dL, P<.032). The present study shows that serum hs-CRP is significantly associated with left ventricular diastolic function and concentric hypertrophy in patients with hypertension.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26603359      PMCID: PMC8031661          DOI: 10.1111/jch.12734

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  34 in total

1.  Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.

Authors:  R B Devereux; N Reichek
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

Review 2.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

3.  High-sensitivity C-reactive protein and parameters of left ventricular dysfunction.

Authors:  Sanjiv J Shah; Gregory M Marcus; Ivor L Gerber; Barry H McKeown; Joshua C Vessey; Mark V Jordan; Michele Huddleston; Elyse Foster; Kanu Chatterjee; Andrew D Michaels
Journal:  J Card Fail       Date:  2006-02       Impact factor: 5.712

4.  Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.

Authors:  Lars Wallentin; Ziad Hijazi; Ulrika Andersson; John H Alexander; Raffaele De Caterina; Michael Hanna; John D Horowitz; Elaine M Hylek; Renato D Lopes; Signild Asberg; Christopher B Granger; Agneta Siegbahn
Journal:  Circulation       Date:  2014-10-07       Impact factor: 29.690

5.  Low-grade inflammation and microalbuminuria in hypertension.

Authors:  Roberto Pedrinelli; Giulia Dell'Omo; Vitantonio Di Bello; Giovanni Pellegrini; Laura Pucci; Stefano Del Prato; Giuseppe Penno
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-10-14       Impact factor: 8.311

6.  C-reactive protein and the risk of developing hypertension.

Authors:  Howard D Sesso; Julie E Buring; Nader Rifai; Gavin J Blake; J Michael Gaziano; Paul M Ridker
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

7.  Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients.

Authors:  Maria Lorenza Muiesan; Massimo Salvetti; Cristina Monteduro; Bianca Bonzi; Anna Paini; Sara Viola; Paolo Poisa; Damiano Rizzoni; Maurizio Castellano; Enrico Agabiti-Rosei
Journal:  Hypertension       Date:  2004-03-08       Impact factor: 10.190

8.  Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure.

Authors:  W H Wilson Tang; Kevin Shrestha; Frederick Van Lente; Richard W Troughton; Maureen G Martin; Allen G Borowski; Sue Jasper; Allan L Klein
Journal:  Am J Cardiol       Date:  2008-02-01       Impact factor: 2.778

9.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.

Authors:  M J Koren; R B Devereux; P N Casale; D D Savage; J H Laragh
Journal:  Ann Intern Med       Date:  1991-03-01       Impact factor: 25.391

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  2 in total

1.  Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy.

Authors:  Tiegang Li; Weiqi Wang; Wenqiang Gan; Silin Lv; Zifan Zeng; Yufang Hou; Zheng Yan; Rixin Zhang; Min Yang
Journal:  Aging (Albany NY)       Date:  2022-02-14       Impact factor: 5.682

2.  The Relationship Between High-Sensitivity C-Reactive Protein Levels and Left Ventricular Hypertrophy in Patients With Newly Diagnosed Hypertension.

Authors:  Ergun Seyfeli; Bahadir Sarli; Hayrettin Saglam; Can Y Karatas; Eyup Ozkan; Mehmet Ugurlu
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-11-24       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.